Verified Nov 2026
Other
·

Bernards, New Jersey
·
Since 2005
Daiichi Sankyo is a global pharmaceutical company headquartered in Bernards, New Jersey, founded in 2005, with 10,000-50,000 employees and revenue exceeding $10 billion. The company operates across oncology, medical, and automotive-related sectors, with particular expertise in antibody-drug conjugate technology and cancer therapeutics including Enhertu and Lixiana.
Daiichi Sankyo, Inc at a glance
Revenue
$10B+
Est. band
Employees
10,000-50,000
Founded
2005
Headquarters
Bernards, New Jersey
Certifications
ISO 14001 · ISO 45001
Import activity
42
Industries
Automotive
Electric Vehicles
Medical
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
42
Named foreign suppliers
37
Top origins
Singapore · Republic of Korea

Shared foreign counterparties do not establish that these companies buy from Daiichi Sankyo, Inc.
What this tells a buyer
The company received 42 recorded shipments, predominantly sourced from Japan, with suppliers including Mr Go Saito (5 shipments) and multiple other Japanese partners, alongside imports from Singapore and the Republic of Korea.
Daiichi Sankyo holds ISO 14001 and ISO 45001 certifications and maintains a clinical development pipeline in oncology supported by partnerships with AstraZeneca and other major pharmaceutical firms.
The company announced $1.9 billion in capital investment across production lines in China and the United States as of early 2026, and established a new Toronto headquarters to support oncology innovation and expansion in the Asia-Pacific region.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
21 years in operation (founded 2005).
42 US import shipments on record.
Holds ISO 14001, ISO 45001 certification(s) per public sources.
Overview
Daiichi Sankyo is a global pharmaceutical company headquartered in Bernards, New Jersey, founded in 2005, with 10,000-50,000 employees and revenue exceeding $10 billion. The company operates across oncology, medical, and automotive-related sectors, with particular expertise in antibody-drug conjugate technology and cancer therapeutics including Enhertu and Lixiana.
At a glance
Attribute | Detail |
|---|---|
Founded | 2005 |
Headquarters | Bernards, New Jersey |
Employees | 10,000-50,000 |
Revenue | $10B+ (estimated) |
Certifications | ISO 14001 · ISO 45001 |
What Daiichi Sankyo, Inc makes
Daiichi Sankyo holds ISO 14001 and ISO 45001 certifications and maintains a clinical development pipeline in oncology supported by partnerships with AstraZeneca and other major pharmaceutical firms.
Certifications
Daiichi Sankyo, Inc is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 14001 — daiichisankyo.com
ISO 45001 — daiichisankyo.com
Trade and customs footprint
The company received 42 recorded shipments, predominantly sourced from Japan, with suppliers including Mr Go Saito (5 shipments) and multiple other Japanese partners, alongside imports from Singapore and the Republic of Korea. US customs bill-of-lading records list 42 inbound shipments across 37 foreign suppliers, with top origins including Singapore · Republic of Korea.
Latest developments
2026-10-02 — Daiichi Sankyo and AstraZeneca Enter into Clinical Trial Collaboration with Summit Therapeutics to Evaluate Datroway in Combination with Ivonescimab Across Multiple Tumor Types- Daiichi Sankyo US (daiichisankyo.us)
2026-05-11 — Daiichi takes $850M charge, axes facility investment as ADC demand forecast falls - BioSpace (biospace.com)
2026-04-08 — Daiichi Sankyo Partnering With ATLATL Innovation Center to Accelerate APAC Biotech Innovation | Contract Pharma (contractpharma.com)
2026-01-21 — Daiichi-Sankyo-Unveils-New-Toronto-Headquarters-to-Accelerate-Investment-and-Innovation-in-Oncology | The Industrial (theindustrial.in)
2026-01-02 — Daiichi Sankyo to spend $1.9bn on production lines in China, US, elsewhere - Nikkei Asia (nikkei.com)
2025-10-30 — Daiichi Sankyo to spend $600m to keep drug discovery in Japan - Nikkei Asia (nikkei.com)
Company details
The company announced $1.9 billion in capital investment across production lines in China and the United States as of early 2026, and established a new Toronto headquarters to support oncology innovation and expansion in the Asia-Pacific region. Daiichi Sankyo, Inc was founded in 2005, has an estimated 10,000-50,000 employees, and is headquartered in Bernards, New Jersey. On the LightSource stability read it is rated "Established & active": 21 years in operation (founded 2005). 42 US import shipments on record. Holds ISO 14001, ISO 45001 certification(s) per public sources.
Frequently asked questions
What does Daiichi Sankyo, Inc do?
Daiichi Sankyo is a global pharmaceutical company headquartered in Bernards, New Jersey, founded in 2005, with 10,000-50,000 employees and revenue exceeding $10 billion. The company operates across oncology, medical, and automotive-related sectors, with particular expertise in antibody-drug conjugate technology and cancer therapeutics including Enhertu and Lixiana.
Where is Daiichi Sankyo, Inc headquartered?
Daiichi Sankyo, Inc is headquartered in Bernards, New Jersey (211 Mount Airy Road, Bernards, New Jersey, 07920).
When was Daiichi Sankyo, Inc founded?
Daiichi Sankyo, Inc was founded in 2005.
How big is Daiichi Sankyo, Inc?
Daiichi Sankyo, Inc has an estimated 10,000-50,000 employees, with revenue in the $10B+ range (estimated).
What certifications does Daiichi Sankyo, Inc hold?
Daiichi Sankyo, Inc lists ISO 14001 · ISO 45001 on its website. Confirm the certified scope for the specific plant producing your part.
Does Daiichi Sankyo, Inc import from overseas suppliers?
US customs bill-of-lading records show 42 inbound shipments for Daiichi Sankyo, Inc, with top origins including Singapore · Republic of Korea.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
